Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study.
about
Continual Reassessment and Related Dose-Finding DesignsApplication of preclinical data to initiate the modified continual reassessment method for maximum tolerated dose-finding trials.Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data.Competing designs for phase I clinical trials: a review.Stochastic approximation with virtual observations for dose-finding on discrete levels.Phase I studies of chemotherapeutic agents in cancer patients: a review of the designs.Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.Principles of dose finding studies in cancer: a comparison of trial designs.Dose escalation methods in phase I cancer clinical trials.Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicitiesPractical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities.Stochastic Approximation and Modern Model-based Designs for Dose-Finding Clinical Trials.Dose-toxicity models in oncology.An approach for dose finding of drugs in infants: sedation by midazolam studied using the continual reassessment method.Small-sample behavior of novel phase I cancer trial designs.Adaptive Phase I clinical trial design using Markov models for conditional probability of toxicity.Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approachThe continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies.Bayesian model averaging continual reassessment method for bivariate binary efficacy and toxicity outcomes in phase I oncology trials.Phase I (or phase II) dose-ranging clinical trials: proposal of a two-stage Bayesian design.Phase I trial design for drug combinations with Bayesian model averaging.Fractional dose-finding methods with late-onset toxicity in phase I clinical trials.Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study.Research involving the vulnerable sick.Accrual strategies for phase I trials with delayed patient outcome.The continual reassessment method in cancer phase I clinical trials: a simulation study.A pragmatic dose-finding approach using short-term surrogate efficacy outcomes to evaluate binary efficacy and toxicity outcomes in phase I cancer clinical trials.A placebo-controlled Bayesian dose finding design based on continuous reassessment method with application to stroke research.
P2860
Q30431500-5992D6CB-9357-4CE0-926E-D084D7B96199Q30623895-EB425048-165D-4FA2-A21A-27996FA26EFDQ31125934-06C8D1A7-31A9-495A-8F34-A08F9C443956Q34849945-0AA6F134-171B-4585-96E9-78513D6EEB0CQ36142945-BF388082-7445-406D-BBA7-DE65BEF9925FQ36621961-2E51A6D1-01F5-4CD1-9AC1-DA60658EEE8EQ36640945-B5B59B34-73BC-4781-B4F4-6BAFBF884D52Q36795347-B46798D3-B89C-414A-9B9C-7E4AEB7A5378Q37198192-3F3494EA-0B1F-4ED3-8340-7840DFA63A3FQ37270128-B094A680-64A8-403E-BAD3-4160D94FF13BQ37523183-C4558A87-D96C-4AEF-A6E0-8101D7D3A54CQ37825427-14847C6F-2E1A-4475-9681-C38898AB29C1Q37829437-302BE32F-0196-471D-A794-5942DD18F18BQ39226311-E9429AD8-1148-453C-979A-F3BFFB633DEFQ39479987-75310576-A3FE-4B27-BCC2-BB514F376BC2Q40811925-6DE76BCC-9088-421C-BAB3-D0796AAAD995Q42084799-51070984-BCEF-4CD3-ABC7-203E173BECC0Q43745833-B7097263-7B45-4FDC-9B4A-2CF2081063AAQ43782645-1BC3094E-327F-448B-8EFC-CD3D5E1DA620Q44361082-26546706-8F32-4E41-942F-CEAAF958766AQ47751410-74698021-7F49-4B92-921C-EFFD9362F62AQ51198034-B2624CFB-1CD0-42A3-935F-BE4B6921C542Q51541408-B0F9401B-E9B3-4D60-84F8-9B1FF9DC5868Q51962647-3138D293-29A8-4A2E-A949-4E0F2AFBAF94Q52212480-D1001C30-2280-4EB8-8AD6-4D9D46AFAD86Q52394804-9AF40F43-69FB-46D3-A333-3EC015DF9C9CQ53125990-0F318D0D-585C-4944-8230-EE48B37628F2Q55419507-4533E4C5-8FD1-4908-9726-A6F867514FC9
P2860
Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Methods for dose finding studi ...... esults of a Monte Carlo study.
@en
type
label
Methods for dose finding studi ...... esults of a Monte Carlo study.
@en
prefLabel
Methods for dose finding studi ...... esults of a Monte Carlo study.
@en
P356
P1476
Methods for dose finding studi ...... esults of a Monte Carlo study.
@en
P2093
O'Quigley J
P304
P356
10.1002/SIM.4780101104
P407
P577
1991-11-01T00:00:00Z